Ocuphire Pharma Inc. (NASDAQ: OCUP)
$1.96
-0.1000 ( -4.85% ) 292.8K
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.
Market Data
Open
$1.96
Previous close
$2.06
Volume
292.8K
Market cap
$50.29M
Day range
$1.93 - $2.14
52 week range
$1.50 - $4.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Nov 27, 2023 |
4 | Insider transactions | 1 | Nov 27, 2023 |
8-k | 8K-related | 14 | Nov 13, 2023 |
4 | Insider transactions | 1 | Nov 13, 2023 |
4 | Insider transactions | 1 | Nov 13, 2023 |
10-q | Quarterly Reports | 75 | Nov 13, 2023 |
3 | Insider transactions | 2 | Nov 03, 2023 |
4 | Insider transactions | 1 | Nov 03, 2023 |
8-k | 8K-related | 57 | Nov 02, 2023 |
8-k | 8K-related | 17 | Nov 01, 2023 |